Report Highlights
The global viscosupplementation market should grow from $3.2 billion in 2018 to $5.9 billion by 2025 at compound annual growth rates (CAGR) of 9.0% for the period of 2018-2025.
Report Includes
- 39 tables
- An overview of global viscosupplementation market
- Detailed market share of viscosupplementation based on product type, procedure type, injection cycle, and application
- Highlights of current and future market potential of viscosupplementation and a detailed analysis of the competitive environment, regulatory scenario, patent analysis, and drivers, challenges, and trends in market growth
- Knowledge about hyaluronic acid, a lubricating agent and discussion on how it enables smooth movement of bones
- Coverage of minimally invasive viscosupplementation procedures, new product innovations, and rapid product advancements
- Insights into strategic initiatives by major companies including partnerships, agreements, geographic expansions, R&D of products, new product launches, mergers and acquisitions and opportunities for the companies
- Company profiles of major global corporations within this market, including Anika Therapeutics Inc., Bioventus, Chugai Pharmaceuticals Co., Ltd., Sanofi and Seikagaku Corp.
Report Scope
The current report offers a detailed picture of the viscosupplementation market. Viscosupplementation is indicated for the treatment of knee, hip, shoulder and ankle osteoarthritis. Hyaluronic acid viscosupplement is injected into joints to reduce joint pains and treat osteoarthritis.
This report highlights the current and future market potential for viscosupplementation and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as market shares for key market players.
This report details market shares for viscosupplementation based on procedure type, application and geography. Based on procedure type, the market is segmented into Three-Injection cycle, Single-Injection cycle and Five-Injection cycle procedure segments. Based on application, the market is segmented into knee osteoarthritis, hip osteoarthritis and the others segment.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for the year 2018 as the base year, with forecasts for 2019 Through 2025. Estimated values are based on viscosupplement manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
- Artificial Intelligence (AI) in Cancer (BIO196B)
- Nutraceuticals: Global Markets (FOD013J)
- Protective Relays and Circuit Breakers: Global Markets (IAS157B)
- Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
Related Reports
Regenerative Medicines: Bone and Joint Applications
The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets
The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.
Osteoarthritis Therapeutics: Global Markets
The global osteoarthritis therapeutics market should reach $11.2 billion by 2026 from $7.4 billion in 2021 at a compound annual growth rate (CAGR) of 8.6% for the forecast period of 2021 to 2026.
Therapies for Rheumatoid Arthritis: Technologies and Global Markets
The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound annual growth rate (CAGR) of 1.3% from 2015 to 2020.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More